US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist
  • 64.305
  • -1.405-2.14%
Trading Dec 13 10:49 ET
2.16BMarket Cap69.14P/E (TTM)

TransMedics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TransMedics Q3 2024 Earnings Date

Currency：USDOct 28, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
115.00M
108.76M
-6.24M
Miss Est.
+73.11%
+63.72%
-5.42%
EPS
0.31
0.12
-0.19
Miss Est.
+140.30%
+115.38%
-61.82%
Analyst Rating
Buy

Dec 13, 2024

TransMedics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 119.399M --
-- 2024/Q4 -- / 109.620M --
Oct 28, 2024 2024/Q3 108.761M / 114.997M --
-- 2024/Q2 114.305M / 98.957M --
Apr 30, 2024 2024/Q1 96.850M / 83.608M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 119.399M--
--2024/Q4-- / 109.620M--
Oct 28, 20242024/Q3108.761M / 114.997M--
--2024/Q2114.305M / 98.957M--
Apr 30, 20242024/Q196.850M / 83.608M--

Unlock Free Earnings Estimates

TransMedics Earnings Reports

  • TransMedics | 10-Q: Q3 2024 Earnings Report

    Oct 30 04:24

  • TransMedics | 8-K: TransMedics Reports Third Quarter 2024 Financial Results

    Oct 29 04:16

  • TransMedics | 10-Q: Q2 2024 Earnings Report

    Aug 2 04:25

  • TransMedics | 8-K: TransMedics Reports Second Quarter 2024 Financial Results

    Aug 1 05:12

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data